Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Indirect evidence from in vitro studies implicates a functional role for matrix metalloproteinases (MMPs) in the central nervous system (CNS), including induction of neuronal migration during development and enhancement of neurite extension. Few reports have documented the expression of these enzymes in the brain, especially after injury in vivo. The objective of this study was to determine whether MMPs are expressed in various regional areas of rat brain after administration of the neurotoxin, kainic acid. Limbic motor seizures and neuronal degeneration were induced in Sprague–Dawley rats by systemic administration of kainate (10 mg/kg). Rats were subsequently divided into convulsive and non‐convulsive groups, after observing their behaviour in response to the drug. Animals were killed 6, 12, 24, 72 and 168 h (7 days) after injection of kainate. Gelatinases were extracted from various brain regions and assayed by gelatin‐substrate zymography. Levels of glial fibrillary acidic protein (GFAP) in corresponding regions were measured by ELISA. In the absence of treatment, MMP‐2 and MMP‐9 activities were expressed differentially in various brain regions with the highest levels in the hippocampus and the lowest in the cerebellum. In areas from convulsive rats, MMP‐9 activity was markedly elevated at 6 h, and reached a maximum at 12 h after injection of kainate (8.1‐fold hippocampus, 7.7‐fold diencephalon, 7.2‐fold striatum, 5.7‐fold frontal cortex, 5.5‐fold cerebellum, 2.6‐fold midbrain). MMP‐2 activity was induced more than two‐fold in the hippocampus, diencephalon and striatum, to a lesser extent in the frontal cortex and midbrain, and was unchanged in the cerebellum, 72 h after injection. Neither MMP activity was altered in any brain region derived from non‐convulsive rats. Treatment with the GABA A antagonist, bicuculline, resulted in increased levels of MMP‐9, 12 h after drug administration, but no change in levels of MMP‐2 up to 3 days following treatment. GFAP levels were induced 3 days after kainic acid injection in brain regions where MMP‐2 was elevated. Nissl staining displayed the classical, regional neurodegeneration in kainate‐treated animals that exhibited seizures. No obvious degeneration was detected in kainate‐treated, non‐convulsive rats or bicuculline‐treated animals. These data demonstrate that MMP‐9 and MMP‐2 are differentially expressed with respect to time after kainic acid injection, and suggest that they are regulated by convulsion and/or neurodegenerative‐associated mechanisms, respectively. Although similar in catalytic activity, MMP‐9 and MMP‐2 may play different roles in response to kainic acid‐induced seizure and neuronal degeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuronal Death in the Hippocampus Is Promoted by Plasmin-Catalyzed Degradation of Laminin
Chen, Z.-L., & Strickland, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80483-3 · Cited by 632
Backstrom, J. R., Lim, G. P., Cullen, M. J., & Tökés, Z. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07910.1996 · Cited by 331 · cited 2×
“Because latent forms of MMP-9 accumulate in the brain tissue of Alzheimer’s patients, the lack of enzyme activation has been suggested to contribute to the accumulation of insolubleβ-amyloid peptides in plaques (Backstrom et al., 1996).”
BackgroundPERESS, N., PERILLO, E. D., & ZUCKER, S. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199501000-00002 · Cited by 81
Neuroimmunology of Alzheimer's disease: A conference report
Dickson, D. W., & Rogers, J. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90104-6 · Cited by 44 · cited 1×
“Since a plethora of immune/inflammatory markers has been identified in neuritic plaques of Alzheimer’s disease (Dickson & Rogers, 1992; Strausset al., 1992) and other neurodegenerative diseases, it suggests that factors present locally in these diseases may regulate the expression of MMPs.”
Background
Cited by
Matrix metalloproteinase-9 is required for hippocampal late-phase long-term potentiation and memory
Nagy, V., Bozdagi, O., Matynia, A., Balcerzyk, M., Okulski, P., Dzwonek, J., Costa, R. M., Silva, A. J., Kaczmarek, L., & Huntley, G. W. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4359-05.2006 · Cited by 499
Szklarczyk, A., Lapinska, J., Rylski, M., McKay, R. D. G., & Kaczmarek, L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00920.2002 · Cited by 392
MMP‐9 in translation: from molecule to brain physiology, pathology, and therapy
Vafadari, B., Salamian, A., & Kaczmarek, L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13415 · Cited by 382
Meighan, S. E., Meighan, P. C., Choudhury, P., Davis, C. J., Olson, M. L., Zornes, P. A., Wright, J. W., & Harding, J. W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03565.x · Cited by 285
Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain
Dzwonek, J., Rylski, M., & Kaczmarek, L. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.070 · Cited by 256
Metadata
- Authors
- Zhang, J. W., Deb, S., & Gottschall, P. E.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 1998-11
- Volume
- 10
- Issue
- 11
- Pages
- 3358-3368
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2130149492
- Cited by
- 109
- References
- 4
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. https://app.cochat.ai/papers/10.1046/j.1460-9568.1998.00347.x
- The paper
- Zhang, J. W., Deb, S., & Gottschall, P. E. (1998). Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration. European Journal of Neuroscience. https://doi.org/10.1046/j.1460-9568.1998.00347.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.